Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Interferon gamma-inducible protein-10 (IP-10) and eotaxin as biomarkers in age-related macular degeneration.

Mo FM, Proia AD, Johnson WH, Cyr D, Lashkari K.

Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4226-36. doi: 10.1167/iovs.09-3910. Epub 2010 Mar 10.

PMID:
20220052
3.

Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, Mooy CM.

Invest Ophthalmol Vis Sci. 2003 May;44(5):2192-8.

PMID:
12714661
5.

Effects of vitrectomy on age-related macular degeneration.

Roller AB, Mahajan VB, Boldt HC, Abramoff MD, Russell SR, Folk JC.

Ophthalmology. 2010 Jul;117(7):1381-6. doi: 10.1016/j.ophtha.2009.11.007. Epub 2010 Feb 21.

PMID:
20176401
7.

Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration.

Erie JC, Good JA, Butz JA, Pulido JS.

Am J Ophthalmol. 2009 Feb;147(2):276-282.e1. doi: 10.1016/j.ajo.2008.08.014. Epub 2008 Oct 9.

PMID:
18848316
8.

Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.

Kamei M, Yoneda K, Kume N, Suzuki M, Itabe H, Matsuda K, Shimaoka T, Minami M, Yonehara S, Kita T, Kinoshita S.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1801-7.

PMID:
17389514
9.

Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration.

Bhutto IA, Kim SY, McLeod DS, Merges C, Fukai N, Olsen BR, Lutty GA.

Invest Ophthalmol Vis Sci. 2004 May;45(5):1544-52.

PMID:
15111613
10.

Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.

Kikuchi M, Nakamura M, Ishikawa K, Suzuki T, Nishihara H, Yamakoshi T, Nishio K, Taki K, Niwa T, Hamajima N, Terasaki H.

Ophthalmology. 2007 Sep;114(9):1722-7. Epub 2007 Apr 2.

PMID:
17400294
11.

Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.

Thill M, Strunnikova NV, Berna MJ, Gordiyenko N, Schmid K, Cousins SW, Thompson DJ, Csaky KG.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2696-708. doi: 10.1167/iovs.07-0955.

PMID:
18515596
12.
13.

Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration.

McLeod DS, Taomoto M, Otsuji T, Green WR, Sunness JS, Lutty GA.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1986-93.

PMID:
12037009
14.

Choroidal neovascular membranes express toll-like receptor 3.

Maloney SC, Antecka E, Orellana ME, Fernandes BF, Odashiro AN, Eghtedari M, Burnier MN Jr.

Ophthalmic Res. 2010;44(4):237-41. doi: 10.1159/000313989. Epub 2010 Aug 10.

PMID:
20699627
15.

Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.

Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group.

Ophthalmology. 2008 Sep;115(9):1474-9, 1479.e1-6. doi: 10.1016/j.ophtha.2008.03.008. Epub 2008 May 27.

PMID:
18502512
16.
17.

The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.

Chowers I, Wong R, Dentchev T, Farkas RH, Iacovelli J, Gunatilaka TL, Medeiros NE, Presley JB, Campochiaro PA, Curcio CA, Dunaief JL, Zack DJ.

Invest Ophthalmol Vis Sci. 2006 May;47(5):2135-40.

PMID:
16639025
18.

The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration.

Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA.

Ophthalmology. 1999 May;106(5):910-9.

PMID:
10328389
19.

Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.

Wilson HL, Schwartz DM, Bhatt HR, McCulloch CE, Duncan JL.

Am J Ophthalmol. 2004 Apr;137(4):615-24.

PMID:
15059698
20.

Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy.

Vogt SD, Curcio CA, Wang L, Li CM, McGwin G Jr, Medeiros NE, Philp NJ, Kimble JA, Read RW.

Exp Eye Res. 2011 Oct;93(4):413-23. doi: 10.1016/j.exer.2011.06.002. Epub 2011 Jun 12.

Supplemental Content

Support Center